Resources

India faced substantial challenges amid the COVID–19 pandemic, when navigating multiple waves that strained the health care system, affecting millions. In response, the STAR 3ACP project in India, led by PSI and implemented in collaboration with PATH, Jhpiego, International Labour Organization, and with technical oversight from the WHO, addressed COVID–19 challenges through evidence generation, supply chain strengthening, policy development, and demand creation. This factsheet outlines the key activities and outcomes, emphasizing the country's pandemic response and enhanced preparedness for future health emergencies.

This retrospective observational study is among the first to assess the impact of neonicotinoid-based indoor residual spraying on malaria case incidence. (In French)

This briefing paper describes a study to assess the current and planned state of vaccine manufacturing capacity in Africa, and provides insights into what is needed to develop a robust and sustainable vaccine manufacturing ecosystem.African vaccine manufacturing is set to expand dramatically as the continent works to safeguard itself against future pandemics and disease outbreaks—but with so many new projects on the horizon, a clear picture of gaps and needs is necessary to ensure all stakeholders are aligned and investments can succeed.This research can help stakeholders, governments, and funders better coordinate and prioritize development efforts, interventions, and investments.

This summary report highlights key takeaways from the co-branded event – ‘Global Vaccine Research Collaborative: Building Consensus for Future Health Emergencies Prevention, Preparedness, and Response’ – held on June 3, 2023, in Hyderabad, India. Organized by the Department of Pharmaceuticals, Government of India, PATH, and CEPI, the event was aimed at building a consensus among various stakeholders engaged in vaccine research, regulation, development, and manufacturing in G20 member states and special invitee countries.

Building on prior analytic and review efforts, this 2023 updated proposal review supported by UNICEF, aims to analyze if and how digital aspects have been included in COVID–19 funding requests for vaccine deployment. The following presentation explores these questions, including the study approach involving key activities.Additionally, the workbook provides details on the methodological approach and categorization/analysis of all examined proposals included in this UNICEF–supported analysis effort. This workbook informed the analysis and recommendations found in the accompanying slide presentation.A related publication to this study is also available in The Lancet Digital Health.